Upcoming collaboration: Two leading pharma company stocks to watch out for
Upcoming collaboration: Two leading pharma company stocks to watch out for

Upcoming collaboration: Two leading pharma company stocks to watch out for

US FDA approved a benzyl alcohol and propylene glycol-free formulation to minimize gasping syndrome risk, for the treatment of seizures in newborns

Kiran Shroff Article rating: 4.5

Upcoming collaboration: Two leading pharma company stocks to watch out for                                                                                                                                                                                            US FDA approved a benzyl alcohol and propylene glycol-free formulation to minimize gasping syndrome risk, for the treatment of seizures in newborns.

Multibagger Alert: Shares of this manufacturing company soared 1,767 per cent in just two years! Do you own this stock?
Multibagger Alert: Shares of this manufacturing company soared 1,767 per cent in just two years! Do you own this stock?

Multibagger Alert: Shares of this manufacturing company soared 1,767 per cent in just two years! Do you own this stock?

This multi-bagger stock has surged 135 per cent on a YTD basis and generated returns of 1,767 per cent in just two years! This means Rs 1 lakh invested in 2020 would have amounted to Rs 18.67 lakh today!! 

Sayali Kotwal Article rating: 3.8

The shares of this company have made a fresh 52-week high at Rs 192.80 piece on September 16 (Friday).  

The stock has been hitting back-to-back upper circuits for a week and got locked in the 5 per cent upper circuit on Friday as well.  

RSS

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR